Pineocytoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Pineocytoma}} {{CMG}}{{AE}}{{SR}}{{Homa}} ==Overview== ==Epidemiology and Demographics== ===Incidence=== *The incidence/prevalence of [disease name] is approxima...")
 
No edit summary
 
Line 41: Line 41:


===Developing Countries===
===Developing Countries===
==Epidemiology==
===Prevalence===
*Pineocytoma constitutes approximately 45% of the pineal parenchymal tumors.<ref name="HiratoNakazato2001">{{cite journal|last1=Hirato|first1=Junko|last2=Nakazato|first2=Yoichi|journal=Journal of Neuro-Oncology|volume=54|issue=3|year=2001|pages=239–249|issn=0167594X|doi=10.1023/A:1012721723387}}</ref><ref name="epipineo12" />
*Pineocytoma constitutes approximately 0.4 - 1% of the intracranial neoplasms.<ref name="ClarkSughrue2011">{{cite journal|last1=Clark|first1=Aaron J.|last2=Sughrue|first2=Michael E.|last3=Aranda|first3=Derick|last4=Parsa|first4=Andrew T.|title=Contemporary Management of Pineocytoma|journal=Neurosurgery Clinics of North America|volume=22|issue=3|year=2011|pages=403–407|issn=10423680|doi=10.1016/j.nec.2011.05.004}}</ref>
===Age===
*Pineocytoma is a rare disease that tends to affect all age groups, most commonly in the second decade of life.<ref name="epipineo12">Epidemiology of pineocytoma. Dr Bruno Di Muzio and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pineocytoma. Accessed on November 20, 2015</ref>


==References==
==References==

Latest revision as of 14:55, 10 October 2019


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2] Homa Najafi, M.D.[3]

Overview

Epidemiology and Demographics

Incidence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.

Prevalence

  • The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
  • In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
  • The prevalence of [disease/malignancy] is estimated to be [number] cases annually.

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

  • Patients of all age groups may develop [disease name].
  • The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
  • [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
  • [Chronic disease name] is usually first diagnosed among [age group].
  • [Acute disease name] commonly affects [age group].

Race

  • There is no racial predilection to [disease name].
  • [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].

Gender

  • [Disease name] affects men and women equally.
  • [Gender 1] are more commonly affected by [disease name] than [gender 2]. The [gender 1] to [gender 2] ratio is approximately [number > 1] to 1.

Region

  • The majority of [disease name] cases are reported in [geographical region].
  • [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].

Developed Countries

Developing Countries

Epidemiology

Prevalence

  • Pineocytoma constitutes approximately 45% of the pineal parenchymal tumors.[1][2]
  • Pineocytoma constitutes approximately 0.4 - 1% of the intracranial neoplasms.[3]

Age

  • Pineocytoma is a rare disease that tends to affect all age groups, most commonly in the second decade of life.[2]


References

  1. Hirato, Junko; Nakazato, Yoichi (2001). Journal of Neuro-Oncology. 54 (3): 239–249. doi:10.1023/A:1012721723387. ISSN 0167-594X. Missing or empty |title= (help)
  2. 2.0 2.1 Epidemiology of pineocytoma. Dr Bruno Di Muzio and Dr Frank Gaillard et al. Radiopaedia 2015. http://radiopaedia.org/articles/pineocytoma. Accessed on November 20, 2015
  3. Clark, Aaron J.; Sughrue, Michael E.; Aranda, Derick; Parsa, Andrew T. (2011). "Contemporary Management of Pineocytoma". Neurosurgery Clinics of North America. 22 (3): 403–407. doi:10.1016/j.nec.2011.05.004. ISSN 1042-3680.

Template:WH Template:WS